Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions.
about
B Cell Therapies, Approved and Emerging: a Review of Infectious Risk and Prevention During Use.Predictors of Poor Outcome in ANCA-Associated Vasculitis (AAV).Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers.The European Vasculitis Society 2016 Meeting Report.Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.
P2860
Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Repeat cycles of rituximab on ...... o guide retreatment decisions.
@en
Repeat cycles of rituximab on ...... o guide retreatment decisions.
@en-gb
Repeat cycles of rituximab on ...... o guide retreatment decisions.
@nl
type
label
Repeat cycles of rituximab on ...... o guide retreatment decisions.
@en
Repeat cycles of rituximab on ...... o guide retreatment decisions.
@en-gb
Repeat cycles of rituximab on ...... o guide retreatment decisions.
@nl
prefLabel
Repeat cycles of rituximab on ...... o guide retreatment decisions.
@en
Repeat cycles of rituximab on ...... o guide retreatment decisions.
@en-gb
Repeat cycles of rituximab on ...... o guide retreatment decisions.
@nl
P2093
P2860
P50
P6366
P1154
2-s2.0-84942093274
P1476
Repeat cycles of rituximab on ...... o guide retreatment decisions.
@en
P2093
Edward M Vital
Md Yuzaiful Md Yusof
Shouvik Dass
Sudipto Das
P2860
P304
P356
10.1136/ANNRHEUMDIS-2014-206496
P407
P5530
P577
2015-04-08T00:00:00Z
P5875
P6179
1002099704
P6366
2033585718